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The term cerebral small vessel disease (SVD) encom-passes a wide spectrum of pathological processes 
affecting the small vessels of the brain,1 among which, arte-
riolosclerosis, also known as hypertensive microangiopathy, 
is the most common. Lacunar strokes (LS) and hemorrhages 
located in the deep brain regions (nonlobar or deep intrace-
rebral hemorrhage [dICH]) represent the acute symptomatic 
consequences of this progressive microangiopathy. Because 
these two phenotypes share the same pathological substrate,1 
it is still matter of debate why some individuals are more 
prone to develop acute small vessel occlusion, whereas 
others are more susceptible to vascular rupture. To date, few 
studies have attempted to address this issue, with conflicting 
results. Most of the inconsistency arise from methodologi-
cal drawbacks of the study designs, including the relatively 
small number of subjects in some analyses, the exclusion 
of subjects without hypertension in others, as well as the 
lack of a clear distinction between ischemic stroke subtypes 
and between lobar and dICH.2–5 Therefore, in this study we 
aimed at investigating whether differences in individual risk 
factor profile underlie the propensity for developing dICH, 
rather than LS.
Background and Purpose—Although lacunar stroke (LS) and deep intracerebral hemorrhage (dICH) represent acute 
manifestations of the same pathological process involving cerebral small vessels (small vessel disease), it remains unclear 
what factors predispose to one phenotype rather than the other at individual level.
Methods—Consecutive patients with either acute symptomatic LS or dICH were prospectively enrolled as part of a 
multicenter Italian study. We compared the risk factor profile of the 2 subgroups using multivariable logistic regression.
Results—During a time course of 9.5 years, 1931 subjects (1434 LS and 497 dICH; mean age, 71.3±13.3 years; males, 
55.5%) qualified for the analysis. Current smoking was associated with LS (odds ratio [OR], 2.17; P<0.001). Conversely, 
dICH cases were more likely to be hypertensive (OR, 1.87; P<0.001), excessive alcohol consumers (OR, 1.70; 
P=0.001), and more frequently under treatment with warfarin (OR, 2.05; P=0.010) and statins (OR, 3.10; P<0.001). 
Hypercholesterolemia, diabetes mellitus, and antiplatelet treatment were not associated with a specific small vessel 
disease manifestation.
Conclusions—The risk factor profile of dICH differs from that associated with LS. This might be used for disease risk 
stratification at individual level.   (Stroke. 2016;47:2141-2143. DOI: 10.1161/STROKEAHA.116.013722.)
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Methods
For the purpose of the present analysis, we reviewed data from the 
prospectively collected registries of 4 Italian neurological centers. 
Consecutive patients who were admitted between January 2002 and 
July 2011 were considered if their presenting symptoms were con-
sistent with a first-ever acute cerebrovascular event. Eligibility for 
study participation required neuroimaging (computed tomography or 
magnetic resonance imaging) confirmation of LS or dICH. Patients’ 
selection criteria and risk factors definition are provided in the online-
only Data Supplement.
Statistical Analyses
Categorical variables are reported as proportion and continuous vari-
ables as mean (SD). Descriptive differences between groups were 
examined with the χ2 test and 1-way ANOVA F test, when appropri-
ate. Multivariable logistic regression was performed including demo-
graphics (age and sex), as well as hypertension, diabetes mellitus, 
hypercholesterolemia, current smoking, antiplatelet therapy, use of 
oral anticoagulants, statin treatment, and alcohol consumption as 
covariates. P<0.05 on 2-sided test was considered significant. Data 
were analyzed using SPSS v.16 (http://www.spss.com).
Results
A total of 1931 patients fulfilled the inclusion criteria (mean 
age, 71.3±13.3 years; males, 55.5%). Of these, 1434 (74.2%) 
had LS and 497 (25.8%) had dICH. The characteristics of the 
whole study group are summarized in Table 1.
Patients presenting with dICH were more likely to be hyper-
tensive, to have a history of ischemic heart disease, excessive 
alcohol consumption, as well as statin and oral anticoagu-
lant treatment compared with LS subjects. However, current 
smoking and hypercholesterolemia were significantly more 
frequent in the group of patients with LS.
Hypertension, excessive alcohol use, anticoagulant, and 
statin therapy were associated with dICH in the multivariable 
logistic regression model, whereas current smoking was asso-
ciated with LS (Table 2).
Discussion
The main finding of this study is that dICH and LS exhibit 
distinct risk factor profiles.
First, our study corroborates previous findings indicating 
hypertension as major risk factor for dICH.2,6 Our results 
are indirectly supported by previous reports suggesting that 
Table 1. Characteristics of the Study Population
Age, mean (SD), y 71.3 (13.3)
Sex, male, n (%) 1071 (55.5)
History of coronary artery disease, n (%) 179 (9.3)
History of hypertension, n (%) 1412 (73.1)
  Admission systolic blood pressure, mean (SD), mm Hg 154.5 (26.6)
  Admission diastolic blood pressure, mean (SD), mm Hg 83.9 (13.7)
History of diabetes mellitus, n (%) 420 (21.8)
  Admission serum glucose, mean (SD), mg/dL 119.3 (47.4)
History of hypercholesterolemia, n (%) 467 (24.2)
  Admission serum total cholesterol, mean (SD), mg/dL 182.2 (38.9)
Current smoking, n (%) 312 (16.2)
History of excessive alcohol consumption, n (%) 252 (12.9)
Statin treatment, n (%) 167 (8.6)
Antiplatelet treatment, n (%) 413 (21.4)
Oral anticoagulant treatment, n (%) 56 (2.9)
Table 2. Comparison Between dICH and LS Cases
Univariate Analysis Multivariable Regression Analysis
LS (n=1434) dICH (n=497) P Values OR (95% CI)* P Values
Age, mean (SD), y 71.1 (13.3) 71.7 (13.2) 0.809 1.00 (0.99–1.01) 0.521
Sex, male, n (%) 783 (54.6) 288 (57.9) 0.196 0.94 (0.75–1.19) 0.652
History of coronary artery disease, n (%) 115 (8.0) 64 (12.9) 0.001
History of hypertension, n (%) 1014 (70.7) 398 (80.1) <0.001 1.87 (1.43–2.44) <0.001
  Admission systolic blood pressure, mean (SD), mm Hg 151.5 (25.1) 164.6 (29.1) <0.001
  Admission dyastolic blood pressure, mean (SD), mm Hg 82.8 (13.2) 87.4 (14.9) 0.007
History of diabetes mellitus, n (%) 321 (22.4) 99 (19.9) 0.251 0.99 (0.74–1.32) 0.984
  Admission serum glucose, mean (SD), mg/dL 116.7 (46.8) 127.5 (48.5) 0.112
History of hypercholesterolemia, n (%) 367 (25.6) 100 (20.1) 0.014 0.80 (0.60–1.06) 0.125
  Admission serum total cholesterol, mean (SD), mg/dL 183.2 (37.9) 178.8 (41.7) 0.059
Current smoking, n (%) 262 (18.3) 50 (10.1) <0.001 0.46 (0.32–0.66) <0.001
History of excessive alcohol consumption, n (%) 163 (11.4) 89 (17.9) <0.001 1.70 (1.24–2.34) 0.001
Statin treatment, n (%) 66 (6.9) 101 (21.0) <0.001 3.10 (2.22–4.33) <0.001
Antiplatelet treatment, n (%) 319 (22.2) 94 (18.9) 0.118 0.86 (0.64–1.15) 0.336
Oral anticoagulant treatment, n (%) 27 (1.9) 29 (5.8) 0.003 2.05 (1.18–3.56) 0.010
CI indicates confidence interval; dICH, deep intracerebral hemorrhage; LS, lacunar stroke; and OR, odds ratio.
*Reference, LS.
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the benefit of long-term antihypertensive therapy might be 
greater for the prevention of hemorrhagic stroke than of 
brain ischemia.7 Second, as opposed to hypertension, dia-
betes mellitus was not associated with a specific clinical 
manifestation of SVD in our study. This is in an appar-
ent disagreement with previous reports.4 Such discrepancy 
might be explained by the lack of a precise identification 
of ischemic stroke subtypes and of pathogenic subgroups 
of cerebral bleeding based on hemorrhage location (deep 
versus lobar). Third, consistently with previous evidence 
that excessive alcohol intake is an important susceptibil-
ity factor for cerebral bleeding,8 excessive alcohol con-
sumption turned out to be related to dICH in our analysis. 
Conversely, in line with previous findings from Kaplan et 
al,9 current smoking was associated with the occurrence 
of LS. Fourth, as expected, we observed a strong rela-
tionship between oral anticoagulant therapy and dICH,6 
as opposed to a neutral effect of antiplatelet medications. 
Finally, statin use seems related to the hemorrhagic mani-
festation of SVD. Although the benefits of statin treatment 
in primary and secondary prevention of ischemic stroke 
are widely recognized, the association between these mol-
ecules and the risk of cerebral bleeding is still controver-
sial.10 Although this study was not specifically designed to 
investigate this hypothesis, our results are in agreement 
with previous reports suggesting a possible relationship 
between statin therapy and increased risk of ICH.10 Statins 
pleiotropic effects, including reduction of platelet aggrega-
tion and inhibition of the coagulation cascade,11 make the 
relation between statins and cerebral bleeding in subjects 
with underlying SVD biologically plausible.
The major strengths of our study are the large number of par-
ticipants, the homogeneous demographic characteristics of the 
cohort along with the standardized diagnostic workup and eval-
uation of risk factors. Some limits should also be acknowledged. 
The lack of a systematic magnetic resonance imaging screening 
prevented us from investigating the potential role of imaging 
markers, such as white matter lesions and cerebral microbleeds. 
Hospital referral selection bias and the long inclusion period 
may also have affected our analysis. Finally, because of the lack 
of a stroke-free control group, we cannot but speculate that the 
observed associations might represent causality.
Conclusions
Symptomatic clinical manifestations of cerebral SVD may 
depend on distinct risk factor profiles predisposing to bleed-
ing and thrombosis, respectively.
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The study was approved by relevant local authorities at each study site. Written informed 
consent was obtained from all patients (or next of kin). 
The LS subgroup was composed of patients with a clinical subcortical lacunar stroke syndrome 
(1) who did not have surgically amenable ipsilateral carotid artery disease or major risk factors 
for cardioembolic sources of stroke (2). The dICH subgroup was composed of patients with deep 
(non-lobar) hematomas. ICH location was assigned based on admission CT scan by stroke 
neurologists at each participating center. Deep hemorrhages were those selectively involving the 
thalamus, basal ganglia, or brainstem. Multiple concurrent bleeds involving deep and lobar 
territories were defined as mixed ICH and represented an exclusion criterion. Additional 
exclusion criteria for ICH included the presence of trauma, brain tumor, hemorrhagic 
transformation of a cerebral infarction, vascular malformation, or any other perceived cause of 
secondary bleeding. Demographic and clinical information, as well as neuroimaging data were 
ascertained by neurologists in each Center.  
 
Risk factor definition 
 
Subjects were classified as current smokers if they were currently smoking one or more 
cigarettes per day on a regular basis. Hypertension was defined as systolic blood pressure (SBP) 
>140 mm Hg and/or diastolic (DBP) >90 mm Hg out of the acute phase, or using 
pharmacological treatment for hypertension. Hypercholesterolemia was considered as cholesterol 
>240 mg/dL (6.18 mmol/L) out of the acute phase or using pharmacological treatment to lower 
blood lipids. Diabetes mellitus was defined as fasting glucose levels >125 mg/dl (6.94 mmol/L) 
out of the acute phase or current treatment with anti-diabetic drugs. Based on daily alcohol 
consumption subjects were dichotomized into excessive drinkers (>45 g of alcohol) and light-
moderate drinkers or non-drinkers. We also collected information on coronary artery disease 
(medical history of angina, myocardial infarction, coronary artery bypass graft, or percutaneous 
trans-luminal coronary angioplasty, and pre-stroke medications (in particular, warfarin, aspirin or 
other antiplatelet agents). Data were obtained from interviews with patients, next of kin and/or 
attending physicians or general practitioners. Fasting lipids and glucose measurements were 
carried out on venous blood samples obtained within 24 hours of stroke occurrence in each 
participating center, using comparable procedures.  
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